Compare LXFR & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXFR | SOPH |
|---|---|---|
| Founded | 1898 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 460.7M | 462.3M |
| IPO Year | 2002 | 2021 |
| Metric | LXFR | SOPH |
|---|---|---|
| Price | $17.11 | $5.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 145.0K | ★ 394.7K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $384,600,000.00 | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | $5.01 | $19.57 |
| P/E Ratio | $131.23 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.19 | $2.92 |
| 52 Week High | $19.45 | $6.30 |
| Indicator | LXFR | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 46.14 | 57.24 |
| Support Level | $16.68 | $4.63 |
| Resistance Level | $19.45 | $6.30 |
| Average True Range (ATR) | 0.63 | 0.40 |
| MACD | -0.24 | 0.00 |
| Stochastic Oscillator | 23.86 | 54.07 |
Luxfer Holdings PLC is engaged in materials engineering and the manufacture of materials, components, and gas containment products. The company has two reportable segments: Elektron and Gas Cylinders. The Elektron segment produces specialty materials based on magnesium and zirconium for applications in aerospace, defense, automotive, and industrial markets. The Gas Cylinders segment manufactures high-pressure gas containment products using aluminum alloys and carbon composite technologies for use in healthcare, emergency response, aerospace, and alternative fuel transportation markets.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.